| Post a Message | Explore Forums | Browse Stock Messages | Hot Discussions | Top rated Messages | Top Boarders | |
|
|
|
Stride Arcolab
| ||||
NSE Announcements on Stride Arcolab
Posted by :
MMB MessengerTracked by: 0 Boarder
Strides Arcolab Limited has informed the Exchange that "Mr. Elcemar Almeida has resigned from the Board of Directors of the Company"....
BSE Announcements on Stride Arcolab
Posted by :
MMB MessengerTracked by: 0 Boarder
Strides Arcolab Ltd has informed BSE that Mr. Elcemar Almeida has resigned from the Board of Directors of the Company....
NSE Announcements on Stride Arcolab
Posted by :
MMB MessengerTracked by: 0 Boarder
Strides Arcolab Limited has informed the Exchange regarding a press release dated November 03, 2008, titled "Strides Arcolab receives USFDA approval for one more product - Takes total Sterile product approvals to 12". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements)....
BSE Announcements on Stride Arcolab
Posted by :
MMB MessengerTracked by: 0 Boarder
Strides Arcolab Ltd has informed BSE regarding a Press Release dated November 03, 2008 titled "Strides Arcolab received USFDA approval for one more product - Takes total Sterile product approvals to 12"....
BSE Announcements on Stride Arcolab
Posted by :
MMB MessengerTracked by: 0 Boarder
Strides Arcolab Ltd has informed BSE that the Board of Directors have approved the introduction of a new ESOP Scheme titled Strides Arcolab ESOP-2008 (Directors) for issuance of upto 500,000 Options, subject to applicable statutory / regulatory requirements....
NSE Announcements on Stride Arcolab
Posted by :
MMB MessengerTracked by: 0 Boarder
Strides Arcolab Limited has informed the Exchange that the Board of Directors have approved the introduction of a new ESOP Scheme titled Strides Arcolab ESOP-2008 (Directors) for issuance of upto 500,000 Options, subject to applicable statutory/ regulatory requirements....
BSE Announcements on Stride Arcolab
Posted by :
MMB MessengerTracked by: 0 Boarder
Strides Arcolab Ltd has informed BSE about the Standalone & Consolidated unaudited financial results for the Quarter ended Sep 30, 2008....
NSE Announcements on Stride Arcolab
Posted by :
MMB MessengerTracked by: 0 Boarder
Strides Arcolab Limited has informed the Exchange regarding a press release dated October 31, 2008, titled "Q308 Revenue up 32% to Rs. 282 Cr.; Operational EBITDA at Rs. 36.7 Cr. Up 128%; PAT at Rs. 105.40 Cr". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). ...
BSE Announcements on Stride Arcolab
Posted by :
MMB MessengerTracked by: 0 Boarder
Strides Arcolab Ltd has informed BSE regarding a Press Release dated October 31, 2008 titled "Q3 08 Revenue up 32% to Rs 282 Cr"....
NSE Announcements on Stride Arcolab
Posted by :
MMB MessengerTracked by: 0 Boarder
Strides Arcolab Limited has informed the Exchange regarding the standalone Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 16632.34 lacs for quarter ending on 30-SEP-2008 against Rs. 10586.4 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. (5167.61) lacs for the quarter ending on 30-SEP-2008 against Rs. 24.9 lacs for the quarter ending on 30-SEP-2007....
NSE Announcements on Stride Arcolab
Posted by :
MMB MessengerTracked by: 0 Boarder
Strides Arcolab Limited has informed the Exchange regarding the consolidated Results for the quarter ended on 30-SEP-2008 as follows: Net Sales of Rs. 27210.33 lacs for quarter ending on 30-SEP-2008 against Rs. 20429.3 lacs for the quarter ending on 30-SEP-2007. Net Profit / (Loss) of Rs. 10534.9 lacs for the quarter ending on 30-SEP-2008 against Rs. (1190) lacs for the quarter ending on 30-SEP-2007....
More from the Pharmaceuticals Sector
Boarders tracking Stride Arcolab
News Updates on Stride Arcolab






Online





see more


